Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07494136 · ClinicalTrials.gov registry record · Phase 4
Dose Dependent Steroid Injections
A Phase 4 study, sponsored by University of Miami.
- Not yet
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT07494136: Clinical Trial Phase 4 study, sponsored by University of Miami.
NCT07494136 is a Phase 4 study that has not yet begun recruiting, run by University of Miami. The registered enrollment target is 150 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07494136, a Phase 4 study, has not yet begun recruiting, sponsored by University of Miami.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study aims to evaluate the efficacy of interlaminar steroid injections at treating pain in lumbar radiculopathy at varying doses, to evaluate the efficacy of interlaminar steroid injections at improving quality of life and function in lumbar radiculopathy at varying doses, and to evaluate difference in efficacy between triamcinolone and dexamethasone interlaminar steroid injections at treating pain in lumbar radiculopathy at varying doses, with the overarching hypotheses that there is no difference in reported pain reduction, quality of life, or function among patients receiving low, moderate, or high doses, and no difference in reported pain reduction between triamcinolone and dexamethasone.
Primary Outcome
Pain intensity will be measured using the Numeric Rating Scale (NRS), a validated 0-10 verbal rating scale in which participants rate their pain on a continuum from 0 (pain) to 10 (max pain). Higher scores indicate greater pain severity.
Interventions
- DRUG Dexamethasone 4mg
- DRUG Triamcinolone 10 Mg/mL Injectable Suspension
- DRUG Triamcinolone 40 Mg/mL Injectable Suspension
- DRUG Triamcinolone 80 Mg/mL Injectable Suspension
- DRUG Dexamethasone 2 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-05 |
| Est. Completion | 2027-05 |
| Phase | Phase 4 |
What is known before NCT07494136 opens enrollment
NCT07494136 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 5 interventions - of which Dexamethasone 4mg is the first listed.
NCT07494136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07494136 about?
NCT07494136 is a clinical study titled "Dose Dependent Steroid Injections". This study aims to evaluate the efficacy of interlaminar steroid injections at treating pain in lumbar radiculopathy at varying doses, to evaluate the efficacy of interlaminar steroid injections at improving quality of life and function in lumbar radiculopathy at varying doses, and to evaluate diffe...
What is the current status of trial NCT07494136?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2026-05. Estimated completion is 2027-05.
What interventions are being tested in trial NCT07494136?
The interventions under investigation include: Dexamethasone 4mg (DRUG), Triamcinolone 10 Mg/mL Injectable Suspension (DRUG), Triamcinolone 40 Mg/mL Injectable Suspension (DRUG), Triamcinolone 80 Mg/mL Injectable Suspension (DRUG), Dexamethasone 2 MG (DRUG).
Who is sponsoring clinical trial NCT07494136?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07494136's enrollment target sits among peer trials
150 533rd of 2000 higher than 1,436 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia